Atlas Trials

EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

RecordFirmDate
Europe-Japan Diagnostic Study for EGFR Testing (NCT01785888)AstraZeneca2013-04-01

Track EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies. automatically

Every clearance here is in the API, with alerts when new ones post.